- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01387919
Time Course and Nature of Nutrient Sensing During Fasting in Humans
July 8, 2011 updated by: Leiden University Medical Center
Several studies have begun to determine the time course of events sensing energy availability in rodents.
In contrast, there is not a single study that has examined this in humans to date.
A better understanding of this energy sensing machinery in humans is of utmost importance to give us new insights into developing new therapies for common diseases such as obesity, diabetes mellitus, cardiovascular diseases and cancer.
In these diseases, disturbances in the energy-sensing machinery possibly play a role.
To determine the time course of energy sensing events in humans, the investigators will measure the concentration of various hormones in plasma, and biochemical changes in skeletal muscle at sequential time points during starvation in humans.
The investigators choose to study the molecular machinery in muscle, since muscle is very sensitive to fuel deprivation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zuid-Holland
-
Leiden, Zuid-Holland, Netherlands, 2333ZA
- Leiden University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 29 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy males
- Age 19-29 years old
- Body mass index (BMI) 19-25 kg/m2
- Stable weight for the last 3 months
- Caucasian
- Fasting plasma glucose (FPG) < 6 mmol/L
- Well-controlled blood pressure (< 150/95 mmHg)
- Creatinine <100 umol/l
- Hb > 7.5 mmol/l
- Negative family history (first degree) of type 2 diabetes mellitus (DM2)
Exclusion Criteria:
- Use of medication known to affect glucose metabolism (for example prednisone) or lipid metabolism
- Significant (chronic) disease
- Smoking (current)
- Alcohol consumption of more than 14 units per week at present or in the past
- Difficult accessible veins for insertion of an intravenous catheter
- Recent blood donation (within the last 3 months)
- Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year
- Rigorous exercise/sports 5 or more days a week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
healthy young and lean men
|
48 hours of fasting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in several proteins/ribonucleic acid (RNA) from muscle biopsies upon fasting
Time Frame: 1.5h, 4h, 10h, 24h
|
1.5h, 4h, 10h, 24h
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in several hormones, lipids etc. from blood samples upon fasting
Time Frame: 1.5h, 4h, 10h, 24h
|
1.5h, 4h, 10h, 24h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hanno Pijl, MD, PhD, Leiden University Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
March 1, 2011
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
July 1, 2011
First Submitted That Met QC Criteria
July 5, 2011
First Posted (Estimate)
July 6, 2011
Study Record Updates
Last Update Posted (Estimate)
July 11, 2011
Last Update Submitted That Met QC Criteria
July 8, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- P10.164
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prolonged fasting
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationTerminatedFertility Issues | Fertility Disorders | IVF | Sub Fertility, Female | Sub-fertilityGermany
-
University of BathUniversity of NottinghamActive, not recruitingAdiposity | Metabolic Disturbance | Fasting | Energy Supply; DeficiencyUnited Kingdom
-
Shanghai University of Traditional Chinese MedicineUnknown
-
Charite University, Berlin, GermanyActive, not recruitingRheumatoid Arthritis | Osteoarthritis, Knee | Metabolic Syndrome | Fibromyalgia | Osteoarthritis, HipGermany
-
Wageningen UniversityCompletedFasting | Clinical Trial | Lipid Metabolism | Adipose TissueNetherlands
-
Arizona State UniversityRecruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Weight Loss | Fasting | MGUS | Cancer Prevention | Smoldering Waldenstrom Macroglobulinemia(WM)United States
-
Memorial Sloan Kettering Cancer CenterRockefeller UniversityRecruitingChildhood Cancer SurvivorsUnited States
-
Arizona State UniversityCompletedMidlife Obese Adults With Cognitive DeclineUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAmerican Cancer Society, Inc.Active, not recruitingHead and Neck CancerUnited States